← Back to Search

MR Elastography (MRE) and FibroScan for Primary Sclerosing Cholangitis

N/A

Waitlist Available

Led By Kartik Jhaveri, MD

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the elastography will be done at the time when the participant would be undergoing their normal clinical care, at the time specified by the primary care physician's order (within 3 months of the mri examination)

Awards & highlights

Study Summary

This trial will use MR Elastography (MRE) to estimate liver fibrosis in people with Primary sclerosing cholangitis (PSC), a chronic liver disease. MRE is a non-invasive tool that may help provide an accurate assessment of disease status to determine optimal treatment.

Eligible Conditions

Magnetic Resonance Imaging (MRI)
Primary Sclerosing Cholangitis
Elastography
Liver Fibrosis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the elastography will be done at the time when the participant would be undergoing their normal clinical care, at the time specified by the primary care physician's order (within 3 months of the mri examination)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the elastography will be done at the time when the participant would be undergoing their normal clinical care, at the time specified by the primary care physician's order (within 3 months of the mri examination)

This trial's timeline: 3 weeks for screening, Varies for treatment, and the elastography will be done at the time when the participant would be undergoing their normal clinical care, at the time specified by the primary care physician's order (within 3 months of the mri examination) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Validation of fibrosis quantification via MR Elastography

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PSC PatientsExperimental Treatment1 Intervention

MR Elastography, Fibroscan and standard of care biopsy

Group II: Non-PSC PatientsActive Control1 Intervention

MR Elastography, Fibroscan and standard of care biopsy

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor

1,476 Previous Clinical Trials

485,098 Total Patients Enrolled

Kartik Jhaveri, MDPrincipal InvestigatorUniversity Health Network, Toronto

6 Previous Clinical Trials

237 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Recent research and studies

clinicaltrials.govStudy

Disease Status in Primary Sclerosing Cholangitis by Elastography

2014. "Disease Status in Primary Sclerosing Cholangitis by Elastography". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02446665.

~8 spots leftby Apr 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.